Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Michael Richtmyer Appointed As Head of Operations At Integrated Bio Pharma’s Subsidiary

PUBLIC · INBPAug 20, 2026•about 5 hours ago

Position

Head of Operations

Company

INTEGRATED BIOPHARMA

Michael Richtmyer
ManufacturingBiotechnologyHealth CareDietary Supplements

Description

On August 20, 2026, Integrated BioPharma, Inc. announced the appointment of Michael Richtmyer to the position of Head of Operations at Manhattan Drug Company, Inc., a wholly owned subsidiary. This strategic move is aimed at enhancing operational efficiency and driving the company's growth.

Company Information

Company

INTEGRATED BIOPHARMA

About

Integrated Biopharma, Inc. is a Delaware-based biopharmaceutical company specializing in the development and manufacturing of dietary supplements and pharmaceutical products. The company operates through its subsidiaries to provide innovative health solutions. Integrated Biopharma is committed to enhancing the quality of life through science-based health products.

Don't miss INTEGRATED BIOPHARMA's next move

Get an email the moment INTEGRATED BIOPHARMA changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for INTEGRATED BIOPHARMA's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

INTEGRATED BIOPHARMA changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.